trial_id	trial_label	ae_code	ae_kg_id	ae_label	probability
trial_1	placebo	87	KG00098599	diarrhoea	0.11493664979934692
trial_1	placebo	9	KG00098432	Confusion NOS	0.10042201727628708
trial_1	placebo	78	KG00099326	Hypertensive diseases	0.07650096714496613
trial_1	placebo	68	KG00099901	nauseas	0.07024849951267242
trial_1	placebo	17	KG00097991	Asthenia NOS	0.06949563324451447
trial_1	placebo	64	KG00097734	Acrodermatitis, NOS	0.06939271092414856
trial_1	placebo	21	KG00098675	dyspnoea	0.06065639108419418
trial_1	placebo	173	KG00098172	Bronchopneumonia NOS	0.060560066252946854
trial_1	placebo	46	KG00099121	Headache NOS	0.05667763203382492
trial_1	placebo	49	KG00099902	nausea with vomiting	0.05628345161676407
trial_1	placebo	123	KG00099351	hypokalaemia	0.05151456966996193
trial_1	placebo	77	KG00098450	Constipation NOS	0.04866769537329674
trial_1	placebo	177	KG00099299	hyperglycaemia	0.045519303530454636
trial_1	placebo	67	KG00098673	Dyspepsia, NOS	0.04540093615651131
trial_1	placebo	189	KG00101580	Alanine aminotransferase increase	0.044946327805519104
trial_1	placebo	37	KG00097696	Cramps, Abdominal	0.04457617551088333
trial_1	placebo	20	KG00098540	dehydration	0.042086757719516754
trial_1	placebo	79	KG00100317	Insomnia, Primary	0.03985406085848808
trial_1	placebo	14	KG00097852	Anemia NOS	0.03831752762198448
trial_1	placebo	188	KG00101579	Aspartate aminotransferase increase	0.03827749565243721
trial_1	placebo	126	KG00100076	Pain NOS	0.03774569556117058
trial_1	placebo	200	KG00098539	Disorders, Deglutition	0.0374140627682209
trial_1	placebo	228	KG00114657	Weight below normal	0.03608712553977966
trial_1	placebo	114	KG00098933	fevers	0.0352187417447567
trial_1	placebo	151	KG00098274	Infarction, Cerebral	0.03399908170104027
trial_1	placebo	85	KG00098474	coughs	0.0337471179664135
trial_1	placebo	101	KG00097901	Anorexia NOS	0.03164301812648773
trial_1	placebo	96	KG00101679	Unattended death NOS	0.03076091967523098
trial_1	placebo	61	KG00099501	Chronic Kidney Failure	0.030381325632333755
trial_1	placebo	29	KG00099354	hyponatraemia	0.02984757162630558
trial_1	placebo	396	KG00100373	Embolism, Pulmonary	0.02875526063144207
trial_1	placebo	86	KG00098565	Depression, Mental	0.028032202273607254
trial_1	placebo	2	KG00100772	thrombocytopaenia	0.02801087684929371
trial_1	placebo	193	KG00108982	WHITE BLOOD CELL COUNT DECREASED	0.027428748086094856
trial_1	placebo	211	KG00100341	Pruritus NOS	0.025898288935422897
trial_1	placebo	142	KG00100923	Unspecified infectious and parasitic diseases	0.0258466936647892
trial_1	placebo	147	KG00098000	atelectases	0.025624984875321388
trial_1	placebo	350	KG00106765	decreased platelet count	0.025292938575148582
trial_1	placebo	76	KG00100450	Respiratory insufficiency, NOS	0.02512500062584877
trial_1	placebo	269	KG00100399	pyaemia	0.024059005081653595
trial_1	placebo	441	KG00098262	cellulitis nos	0.023897342383861542
trial_1	placebo	30	KG00099500	Acute Kidney Failure	0.023752575740218163
trial_1	placebo	243	KG00100947	Micturition frequency increased	0.02349267713725567
trial_1	placebo	180	KG00099363	Hypotension NOS	0.02299048751592636
trial_1	placebo	122	KG00099321	Hypersensitivity NOS	0.022570211440324783
trial_1	placebo	18	KG00098307	Pain, Chest	0.02212819829583168
trial_1	placebo	234	KG00098669	dysgeusias	0.02202179841697216
trial_1	placebo	104	KG00097963	arthralgias	0.02163073606789112
trial_1	placebo	131	KG00100948	Urinary tract infection (& [NOS])	0.021178288385272026
trial_1	placebo	75	KG00100195	Dolens, Phlegmasia Alba	0.020830510184168816
trial_1	placebo	5	KG00099169	haematuria	0.020620843395590782
trial_1	placebo	261	KG00101559	raised alkaline phosphatase	0.02034885250031948
trial_1	placebo	38	KG00098066	Binocular vision disorders	0.020036878064274788
trial_1	placebo	239	KG00100128	pareses	0.019560763612389565
trial_1	placebo	102	KG00097916	anxieties	0.01942223124206066
trial_1	placebo	191	KG00104055	Biliverdin increased	0.019377144053578377
trial_1	placebo	72	KG00103771	myalgias	0.019364694133400917
trial_1	placebo	194	KG00110727	Neutrophil Count Decreased	0.019222915172576904
trial_1	placebo	69	KG00100082	Palpitations NOS	0.018668383359909058
trial_1	placebo	116	KG00098964	Pain in foot	0.018373265862464905
trial_1	placebo	276	KG00099127	Arrest, Cardiac	0.01809711568057537
trial_1	placebo	130	KG00100683	Stomatitis NOS	0.017900530248880386
trial_1	placebo	121	KG00099190	haemorrhage	0.017863130196928978
trial_1	placebo	28	KG00099347	hypoglycaemia	0.017758792266249657
trial_1	placebo	361	KG00098004	Fibrillation, Atrial	0.017155800014734268
trial_1	placebo	139	KG00098855	Sinusitis, Ethmoid	0.01713954284787178
trial_1	placebo	36	KG00106434	Vision, Blurring Of	0.016582047566771507
trial_1	placebo	136	KG00101582	Dry;skin	0.01645040512084961
trial_1	placebo	31	KG00099872	Infarction, Myocardial	0.016331370919942856
trial_1	placebo	138	KG00098796	epidemic vomiting syndrome	0.016045061871409416
trial_1	placebo	1	KG00099959	Neutropenia NOS	0.015998341143131256
trial_1	placebo	11	KG00097993	Asthma NOS	0.01576024480164051
trial_1	placebo	164	KG00108827	ileus colon	0.015520891174674034
trial_1	placebo	179	KG00099342	hypocalcaemia	0.015506792813539505
trial_1	placebo	154	KG00099686	Lymphopenias	0.015313075855374336
trial_1	placebo	466	KG00101205	fall	0.015089279040694237
trial_1	placebo	27	KG00099303	hyperkalaemia	0.014971446245908737
trial_1	placebo	15	KG00097882	Angina pectoris NOS	0.014734718948602676
trial_1	placebo	82	KG00097697	abdomen distended	0.014730053022503853
trial_1	placebo	186	KG00101431	creatinine increased	0.014695457182824612
trial_1	placebo	118	KG00099011	Gastritis NOS	0.01466326229274273
trial_1	placebo	144	KG00099610	Leukopenia NOS	0.014513690955936909
trial_1	placebo	262	KG00101199	agitation	0.01442156545817852
trial_1	placebo	204	KG00098849	Esophagitis, Peptic	0.014337784610688686
trial_1	placebo	508	KG00108565	blood glucose increased	0.014006872661411762
trial_1	placebo	253	KG00100232	Pleural effusion NOS (disorder)	0.013826421461999416
trial_1	placebo	249	KG00104430	hypoalbuminaemia	0.013694900088012218
trial_1	placebo	300	KG00101064	xerostomia	0.013226604089140892
trial_1	placebo	356	KG00112623	Infectious Lung Disorders	0.013136815279722214
trial_1	placebo	286	KG00101110	Retention, Urinary	0.013002579100430012
trial_1	placebo	355	KG00110857	lymphocyte count decreased	0.012958860024809837
trial_1	placebo	33	KG00100094	Pancreatitis NOS	0.012951457872986794
trial_1	placebo	100	KG00097815	alopecias	0.012725111097097397
trial_1	placebo	97	KG00104198	LIVER ENZYME ELEVATED	0.012678456492722034
trial_1	placebo	92	KG00100926	Infections, Upper Respiratory	0.012671462260186672
trial_1	placebo	221	KG00101207	peripheral oedema	0.012641043402254581
trial_1	placebo	371	KG00098517	Cystitis (NOS)	0.012571529485285282
trial_1	placebo	456	KG00099420	Influenzae	0.012500137090682983
trial_1	placebo	282	KG00099309	hypernatraemia	0.012476908974349499
trial_1	placebo	254	KG00100774	Thrombosis NOS	0.012285981327295303
trial_2	pyrazinamide	87	KG00098599	diarrhoea	0.11493664979934692
trial_2	pyrazinamide	9	KG00098432	Confusion NOS	0.10042201727628708
trial_2	pyrazinamide	78	KG00099326	Hypertensive diseases	0.07650096714496613
trial_2	pyrazinamide	68	KG00099901	nauseas	0.07024849951267242
trial_2	pyrazinamide	17	KG00097991	Asthenia NOS	0.06949563324451447
trial_2	pyrazinamide	64	KG00097734	Acrodermatitis, NOS	0.06939271092414856
trial_2	pyrazinamide	21	KG00098675	dyspnoea	0.06065639108419418
trial_2	pyrazinamide	173	KG00098172	Bronchopneumonia NOS	0.060560066252946854
trial_2	pyrazinamide	46	KG00099121	Headache NOS	0.05667763203382492
trial_2	pyrazinamide	49	KG00099902	nausea with vomiting	0.05628345161676407
trial_2	pyrazinamide	123	KG00099351	hypokalaemia	0.05151456966996193
trial_2	pyrazinamide	77	KG00098450	Constipation NOS	0.04866769537329674
trial_2	pyrazinamide	177	KG00099299	hyperglycaemia	0.045519303530454636
trial_2	pyrazinamide	67	KG00098673	Dyspepsia, NOS	0.04540093615651131
trial_2	pyrazinamide	189	KG00101580	Alanine aminotransferase increase	0.044946327805519104
trial_2	pyrazinamide	37	KG00097696	Cramps, Abdominal	0.04457617551088333
trial_2	pyrazinamide	20	KG00098540	dehydration	0.042086757719516754
trial_2	pyrazinamide	79	KG00100317	Insomnia, Primary	0.03985406085848808
trial_2	pyrazinamide	14	KG00097852	Anemia NOS	0.03831752762198448
trial_2	pyrazinamide	188	KG00101579	Aspartate aminotransferase increase	0.03827749565243721
trial_2	pyrazinamide	126	KG00100076	Pain NOS	0.03774569556117058
trial_2	pyrazinamide	200	KG00098539	Disorders, Deglutition	0.0374140627682209
trial_2	pyrazinamide	228	KG00114657	Weight below normal	0.03608712553977966
trial_2	pyrazinamide	114	KG00098933	fevers	0.0352187417447567
trial_2	pyrazinamide	151	KG00098274	Infarction, Cerebral	0.03399908170104027
trial_2	pyrazinamide	85	KG00098474	coughs	0.0337471179664135
trial_2	pyrazinamide	101	KG00097901	Anorexia NOS	0.03164301812648773
trial_2	pyrazinamide	96	KG00101679	Unattended death NOS	0.03076091967523098
trial_2	pyrazinamide	61	KG00099501	Chronic Kidney Failure	0.030381325632333755
trial_2	pyrazinamide	29	KG00099354	hyponatraemia	0.02984757162630558
trial_2	pyrazinamide	396	KG00100373	Embolism, Pulmonary	0.02875526063144207
trial_2	pyrazinamide	86	KG00098565	Depression, Mental	0.028032202273607254
trial_2	pyrazinamide	2	KG00100772	thrombocytopaenia	0.02801087684929371
trial_2	pyrazinamide	193	KG00108982	WHITE BLOOD CELL COUNT DECREASED	0.027428748086094856
trial_2	pyrazinamide	211	KG00100341	Pruritus NOS	0.025898288935422897
trial_2	pyrazinamide	142	KG00100923	Unspecified infectious and parasitic diseases	0.0258466936647892
trial_2	pyrazinamide	147	KG00098000	atelectases	0.025624984875321388
trial_2	pyrazinamide	350	KG00106765	decreased platelet count	0.025292938575148582
trial_2	pyrazinamide	76	KG00100450	Respiratory insufficiency, NOS	0.02512500062584877
trial_2	pyrazinamide	269	KG00100399	pyaemia	0.024059005081653595
trial_2	pyrazinamide	441	KG00098262	cellulitis nos	0.023897342383861542
trial_2	pyrazinamide	30	KG00099500	Acute Kidney Failure	0.023752575740218163
trial_2	pyrazinamide	243	KG00100947	Micturition frequency increased	0.02349267713725567
trial_2	pyrazinamide	180	KG00099363	Hypotension NOS	0.02299048751592636
trial_2	pyrazinamide	122	KG00099321	Hypersensitivity NOS	0.022570211440324783
trial_2	pyrazinamide	18	KG00098307	Pain, Chest	0.02212819829583168
trial_2	pyrazinamide	234	KG00098669	dysgeusias	0.02202179841697216
trial_2	pyrazinamide	104	KG00097963	arthralgias	0.02163073606789112
trial_2	pyrazinamide	131	KG00100948	Urinary tract infection (& [NOS])	0.021178288385272026
trial_2	pyrazinamide	75	KG00100195	Dolens, Phlegmasia Alba	0.020830510184168816
trial_2	pyrazinamide	5	KG00099169	haematuria	0.020620843395590782
trial_2	pyrazinamide	261	KG00101559	raised alkaline phosphatase	0.02034885250031948
trial_2	pyrazinamide	38	KG00098066	Binocular vision disorders	0.020036878064274788
trial_2	pyrazinamide	239	KG00100128	pareses	0.019560763612389565
trial_2	pyrazinamide	102	KG00097916	anxieties	0.01942223124206066
trial_2	pyrazinamide	191	KG00104055	Biliverdin increased	0.019377144053578377
trial_2	pyrazinamide	72	KG00103771	myalgias	0.019364694133400917
trial_2	pyrazinamide	194	KG00110727	Neutrophil Count Decreased	0.019222915172576904
trial_2	pyrazinamide	69	KG00100082	Palpitations NOS	0.018668383359909058
trial_2	pyrazinamide	116	KG00098964	Pain in foot	0.018373265862464905
trial_2	pyrazinamide	276	KG00099127	Arrest, Cardiac	0.01809711568057537
trial_2	pyrazinamide	130	KG00100683	Stomatitis NOS	0.017900530248880386
trial_2	pyrazinamide	121	KG00099190	haemorrhage	0.017863130196928978
trial_2	pyrazinamide	28	KG00099347	hypoglycaemia	0.017758792266249657
trial_2	pyrazinamide	361	KG00098004	Fibrillation, Atrial	0.017155800014734268
trial_2	pyrazinamide	139	KG00098855	Sinusitis, Ethmoid	0.01713954284787178
trial_2	pyrazinamide	36	KG00106434	Vision, Blurring Of	0.016582047566771507
trial_2	pyrazinamide	136	KG00101582	Dry;skin	0.01645040512084961
trial_2	pyrazinamide	31	KG00099872	Infarction, Myocardial	0.016331370919942856
trial_2	pyrazinamide	138	KG00098796	epidemic vomiting syndrome	0.016045061871409416
trial_2	pyrazinamide	1	KG00099959	Neutropenia NOS	0.015998341143131256
trial_2	pyrazinamide	11	KG00097993	Asthma NOS	0.01576024480164051
trial_2	pyrazinamide	164	KG00108827	ileus colon	0.015520891174674034
trial_2	pyrazinamide	179	KG00099342	hypocalcaemia	0.015506792813539505
trial_2	pyrazinamide	154	KG00099686	Lymphopenias	0.015313075855374336
trial_2	pyrazinamide	466	KG00101205	fall	0.015089279040694237
trial_2	pyrazinamide	27	KG00099303	hyperkalaemia	0.014971446245908737
trial_2	pyrazinamide	15	KG00097882	Angina pectoris NOS	0.014734718948602676
trial_2	pyrazinamide	82	KG00097697	abdomen distended	0.014730053022503853
trial_2	pyrazinamide	186	KG00101431	creatinine increased	0.014695457182824612
trial_2	pyrazinamide	118	KG00099011	Gastritis NOS	0.01466326229274273
trial_2	pyrazinamide	144	KG00099610	Leukopenia NOS	0.014513690955936909
trial_2	pyrazinamide	262	KG00101199	agitation	0.01442156545817852
trial_2	pyrazinamide	204	KG00098849	Esophagitis, Peptic	0.014337784610688686
trial_2	pyrazinamide	508	KG00108565	blood glucose increased	0.014006872661411762
trial_2	pyrazinamide	253	KG00100232	Pleural effusion NOS (disorder)	0.013826421461999416
trial_2	pyrazinamide	249	KG00104430	hypoalbuminaemia	0.013694900088012218
trial_2	pyrazinamide	300	KG00101064	xerostomia	0.013226604089140892
trial_2	pyrazinamide	356	KG00112623	Infectious Lung Disorders	0.013136815279722214
trial_2	pyrazinamide	286	KG00101110	Retention, Urinary	0.013002579100430012
trial_2	pyrazinamide	355	KG00110857	lymphocyte count decreased	0.012958860024809837
trial_2	pyrazinamide	33	KG00100094	Pancreatitis NOS	0.012951457872986794
trial_2	pyrazinamide	100	KG00097815	alopecias	0.012725111097097397
trial_2	pyrazinamide	97	KG00104198	LIVER ENZYME ELEVATED	0.012678456492722034
trial_2	pyrazinamide	92	KG00100926	Infections, Upper Respiratory	0.012671462260186672
trial_2	pyrazinamide	221	KG00101207	peripheral oedema	0.012641043402254581
trial_2	pyrazinamide	371	KG00098517	Cystitis (NOS)	0.012571529485285282
trial_2	pyrazinamide	456	KG00099420	Influenzae	0.012500137090682983
trial_2	pyrazinamide	282	KG00099309	hypernatraemia	0.012476908974349499
trial_2	pyrazinamide	254	KG00100774	Thrombosis NOS	0.012285981327295303
